Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy

Journal of Rheumatology

Volumn 29, Issue 11, 2002, Pages 2442-2445

  Lahdenne, Pekka ^a   Rapola, Juhani ^a   Ylijoki, Heikki ^a   Haapasaari, Jarkko ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hepatotoxicity; Juvenile idiopathic arthritis; Methotrexate

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; DICLOFENAC; HYDROXYCHLOROQUINE; KETOPROFEN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; FIBROSIS; HISTOLOGY; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TOXICITY; MALE; MEDICAL RECORD; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BIOPSY; CHILD; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; METHOTREXATE; TIME FACTORS;

EID: 0036842098     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Giannini EH, Brewer EJ, Kuzmina N, et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. N Engl J Med 1992;326:1043-9.
2. Ravelli A, Gerloni V, Corona F, et al. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Clin Exp Rheumatol 1998;16:181-3.
3. Al-Sewairy W, Al-Mazyed A, Al-Dalaan M, Al-Balaa S, Bahabri S. Methotrexate therapy in systemic-onset juvenile rheumatoid arthritis in Saudi Arabia: A retrospective analysis. Clin Rheumatol 1998;17:52-7.
4. Woo P, Southwood TR, Prieur A-M, et al. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 2000;43:1849-57.
5. Wallace CA, Sherry DD. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. J Rheumatol 1992;19:1604-7.
6. Reiff A, Shabam B, Wood BP, Bernstein BH, Stanley P, Szer IS. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol 1995;13:113-8.
7. Russo RAG, Katsicas MM. Tolerance of parenteral, higher dose methotrexate in children with juvenile chronic arthritis [letter]. Clin Exp Rheumatol 2000;18:425.
8. Brick JE, Moreland LW, Al-Kawas F, Chang WWL, Layne RD, DiBartolomeo AG. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid arthritis. Semin Arthritis Rheum 1989;19:31-44.
9. Kremer JM, Alarcon GS, Lightfoot RW Jr, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37:316-28.
10. Richard S, Guerret S, Gerard F, Tebib JG, Vignon E. Hepatic fibrosis in idiopathic arthritis patients treated with methotrexate: Application of a new semi-quantitative scoring system. Rheumatology 2000;39:50-4.
11. Graham LD, Myones BL, Rivas-Chacon RF, Pachman LM. Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr 1992;120:468-73.
12. Häfner R, Franke J. Liver biopsies in juvenile chronic arthritis with special reference to methotrexate therapy [abstract]. Clin Exp Rheumatol 1994;12:S124.
13. Kugathasan S, Newman JA, Dahms BB, Boyle JT. Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term weekly methotrexate therapy. J Pediatr 1996;128:149-51.
14. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:2226-34.
15. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr 1999;134:47-52.
16. Danao T, Steinbrummer J, Mendendorp SV, Mackenzie AH, Segal AM. Methotrexate in juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1989;32 Suppl 4:S28.
17. Keim D, Ragsdale C, Heidelberger K, Sullivan D. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis. J Rheumatol 1990;17:846-8.
18. Petty R, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
19. Roenigk HH, Auerbach R, Maibach HI, Weinstein GD. Methotrexate guidelines - Revised. J Am Acad Dermatol 1982;6:145-55.
20. Fries JF, Singh G, Lenert L, Furst DE. Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
21. van Ede AE, Laan RFJ, Rood MJ, et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis. Arthritis Rheum 2001;44:1515-24.
22. West SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am 1997;23:883-915.
23. Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis. Med Clin North Am 1996;80:1147-66.
24. Ravelli A, Martini A. Methotrexate in juvenile idiopathic arthritis: Answers and questions. J Rheumatol 2000;27:1830-3.